# Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding

> **NCT07749300** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 100 (estimated)

## Conditions studied

- Acute Upper Gastrointestinal Bleeding
- Upper Gastrointestinal Bleeding
- Gastrointestinal Hemorrhage

## Interventions

- **DRUG:** Trimebutine Maleate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07749300
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-09
- **Final completion:** 2027-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749300, "Trimebutine Maleate for Enhancing Gastric Visualization in Acute Upper Gastrointestinal Bleeding". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07749300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*